Neuronal Ceroid Lipofuscinosis Type 6 · CLN6 · Ceroid-Lipofuszinose Typ 6 · NCL 6 · Neuronal ceroid-lipofuscinosis 6
Neuronal ceroid lipofuscinosis type 6 (NCL6) is an inherited metabolic disorder that affects the nervous system. It occurs when the body fails to properly break down cellular waste, causing fatty pigments called lipofuscins to build up inside nerve cells. This accumulation gradually damages and destroys cells in the brain and other tissues.
Owners typically notice symptoms starting between 1.5 and 2 years of age. These signs include progressive vision loss, disorientation, difficulty coordinating movements, and epileptic seizures.
There is no cure for this condition, and treatment is limited to supportive care to manage symptoms like seizures. This lifelong palliative management typically costs between 1,000 and 3,000 EUR.
Estimated range of typical treatment cost. Actual cost depends on severity, clinic and region.
More conditions affecting the Head / nervous system.